|
MRK
|
Merck & Company, Inc.
|
6.82%
|
US
|
NYSE
|
|
ABT
|
Abbott Laboratories
|
6.70%
|
US
|
NYSE
|
|
ABBV
|
AbbVie Inc.
|
6.66%
|
US
|
NYSE
|
|
PFE
|
Pfizer, Inc.
|
6.54%
|
US
|
NYSE
|
|
GILD
|
Gilead Sciences, Inc.
|
6.52%
|
US
|
NASDAQ
|
|
JNJ
|
Johnson & Johnson
|
6.34%
|
US
|
NYSE
|
|
LLY
|
Eli Lilly and Company
|
6.22%
|
US
|
NYSE
|
|
AMGN
|
Amgen Inc.
|
5.93%
|
US
|
NASDAQ
|
|
HZNP
|
Horizon Pharma, Inc.
|
4.72%
|
US
|
NASDAQ
|
|
SUPN
|
Supernus Pharmaceuticals, Inc.
|
3.63%
|
US
|
NASDAQ
|
|
PRGO
|
Perrigo Company
|
3.61%
|
US
|
NYSE
|
|
PBH
|
Prestige Brand Holdings, Inc.
|
3.54%
|
US
|
NYSE
|
|
EBS
|
Emergent Biosolutions, Inc.
|
3.51%
|
US
|
NYSE
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
3.44%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
3.32%
|
US
|
NASDAQ
|
|
AMPH
|
Amphastar Pharmaceuticals, Inc.
|
3.24%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
3.19%
|
US
|
NASDAQ
|
|
TVTX
|
Travere Therapeutics, Inc.
|
3.12%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
2.94%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
2.75%
|
US
|
NASDAQ
|